These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8231930)

  • 1. Michigan drug utilization review and OBRA 90.
    Sandusky M
    Mich Med; 1993 Apr; 92(4):38-9. PubMed ID: 8231930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
    J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel.
    J Am Pharm Assoc (Wash); 2000; 40(4):538-45. PubMed ID: 10932464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule.
    Fed Regist; 1994 Sep; 59(184):48811-25. PubMed ID: 10137645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug utilization review in the managed care environment.
    Briesacher B; DuChane J
    Med Interface; 1995 Mar; 8(3):72-4, 76-8. PubMed ID: 10141391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ineffectiveness of retrospective drug utilization review.
    Hennessy S; Strom BL
    LDI Issue Brief; 2003 Sep; 9(1):1-4. PubMed ID: 14577443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug utilization review using a Medicaid claims database.
    Sena MM; Pashko S
    Clin Ther; 1993; 15(5):900-4. PubMed ID: 8269457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pennsylvania takes lead in drug education venture.
    Harley NA
    Pa Med; 1993 Jul; 96(7):12-4. PubMed ID: 8414593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A migraine prophylaxis educational intervention in a Medicaid population.
    Owens C; Pugmire B; Owens K
    Headache; 2008 Feb; 48(2):267-71. PubMed ID: 18194289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.
    Grégoire JP; Moisan J; Potvin L; Chabot I; Verreault R; Milot A
    BMC Health Serv Res; 2006 Mar; 6():33. PubMed ID: 16536865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea.
    Yeom JH; Park JS; Oh OH; Shin HT; Oh JM
    Ann Pharmacother; 2005 Nov; 39(11):1918-23. PubMed ID: 16219902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final rule issued on Medicaid DUR and patient counseling.
    Am J Hosp Pharm; 1994 Dec; 51(24):3016, 3019. PubMed ID: 7856617
    [No Abstract]   [Full Text] [Related]  

  • 14. Low cost, manual drug use review of Medicaid recipients to screen prescriber and pharmacist performance.
    Knapp DE; Crosby DL; Burke LB; Dreis MW; Forbes MB; Knapp DA
    Am J Hosp Pharm; 1978 Apr; 35(4):437-40. PubMed ID: 347930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM; Mott DA; Bigelow WE; Zimmerman DR
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug utilization review in ambulatory settings: state of the science and directions for outcomes research.
    Lipton HL; Bird JA
    Med Care; 1993 Dec; 31(12):1069-82. PubMed ID: 8246637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alabama Medicaid DUR Program.
    Guo J; Gibson JT; Allen WO
    Ala Med; 1995 Jul; 65(1):21-2. PubMed ID: 7484668
    [No Abstract]   [Full Text] [Related]  

  • 18. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of patient information on the quality of pharmacists' drug use review decisions.
    Warholak-Juarez T; Rupp MT; Salazar TA; Foster S
    J Am Pharm Assoc (Wash); 2000; 40(4):500-8. PubMed ID: 10932459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug education. Moving ahead the fourth year.
    Seibert DJ
    Pa Med; 1997 Jan; 100(1):22-4, 26. PubMed ID: 9014488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.